Welcome!

News Feed Item

Senior Life Sciences Executives Join Bedrocan as Independent Directors

Health care business leaders strengthen focus of licensed medicinal cannabis producer ahead of August 25th public listing

TORONTO, Aug. 21, 2014 /CNW/ - Bedrocan Cannabis Corp., previously Bedrocan Canada Inc. ("Bedrocan") has appointed three independent members to its Board of Directors, enhancing executive oversight and strengthening the health care experience of the company, a leading licensed producer of medicinal cannabis in Canada. Internationally, Bedrocan has 13 years' experience in producing and supplying government-regulated pharmaceutical-grade cannabis to patients in seven countries, including Canada.

As previously announced in a press release dated August 20, 2014, Bedrocan is expected to begin trading on the TSX-V beginning August 25, 2014 under the symbol "BED".

Bedrocan's new independent directors are Mr. Barry Fishman, former CEO of Teva Canada; Mr. Allan Mandelzys, former CEO and senior executive of publicly-traded biotechnology companies; and Mr. Roderick Budd, former life sciences practice leader at Ernst & Young. The new appointees join existing Bedrocan directors Mr. Marc Wayne, President and CEO of Bedrocan, and Chairman of the Board Mr. Murray Goldman, the founder and Chairman of the Goldman Group.

Mr. Fishman will be a Board Member and has agreed to chair the Compensation Committee of Bedrocan's Board. Until the end of 2013, Mr. Fishman was President and CEO of Teva Canada, a leading pharmaceutical company generating up to $1 billion in revenue in Canada. Previously, as CEO of Taro Canada, a specialty pharmaceutical company, Mr. Fishman tripled sales, strengthened talent and improved profitability. Prior to Taro, Mr. Fishman spent 17 years with Eli Lilly Canada where he advanced through several cross-functional leadership roles, including Vice President of Marketing.

"We are seeing the emergence of a new medicinal cannabis industry in Canada, and I am excited to join the Bedrocan team as the company seeks to set the highest standards in this industry for professionalism, product quality, research and patient care," said Mr. Fishman.

Mr. Budd will be a Board Member and has agreed to chair the Audit Committee of Bedrocan's Board.  Mr. Budd was a partner at Ernst & Young for 25 years until his retirement in 2010. For the last eight years he was the Canadian firm's life sciences practice leader. Mr. Budd has over 36 years of experience in public accounting serving emerging and growth companies with a focus on those in the life sciences sector. He has experience with public companies in both Canada and the United States, having assisted in more than a dozen IPOs and numerous secondary issues in the past 15 years. He currently holds board positions in several other companies and industry leading organizations.

Mr. Mandelzys will be a Board Member at Bedrocan. He is an accomplished biotechnology executive with twenty years of experience, most recently as CEO of a clinical stage, publicly-traded pharmaceutical company. Mr. Mandelzys is a business development professional with more than fifteen years of successfully leading negotiations and executing strategic partnerships, which include product in-licensing and out-licensing agreements, merger and acquisition transactions, research alliances and master service agreements. He has a proven track record in raising capital (more than $200 million) and communicating effectively with investors, media and external stakeholders.

"With their deep experience in the pharmaceutical, biotechnology and life sciences sectors, the addition of Barry, Rod and Allan to Bedrocan's Board of Directors will continue to build our strength as a leading health care company focused on product quality, research, and patient care," said Mr. Wayne.

About Bedrocan

Bedrocan is the global leader in medicinal cannabis research and product innovation and has been producing and supplying government-regulated medicinal cannabis for 13 years. Bedrocan's strains of pharmaceutical-grade cannabis are used by patients in seven countries, including Canada. The company is committed to clinical research with ISO 9001-rated production processes and product development, on an international scale. Bedrocan is one of only two companies currently supplying pharmaceutical-grade medicinal cannabis in Canada. 

SOURCE Bedrocan Canada Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
When applications are hosted on servers, they produce immense quantities of logging data. Quality engineers should verify that apps are producing log data that is existent, correct, consumable, and complete. Otherwise, apps in production are not easily monitored, have issues that are difficult to detect, and cannot be corrected quickly. Tom Chavez presents the four steps that quality engineers should include in every test plan for apps that produce log output or other machine data. Learn the ste...
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
Is it possible to migrate 100% of your data ecosystem to the cloud? Join Joe Caserta as he takes you on a complete journey to digital transformation mapping out on-prem data footprint and walking it to the cloud. Joe will also explain how the modern ecosystem supports Artificial Intelligence and will include business use cases to back each of his insights.
Your job is mostly boring. Many of the IT operations tasks you perform on a day-to-day basis are repetitive and dull. Utilizing automation can improve your work life, automating away the drudgery and embracing the passion for technology that got you started in the first place. In this presentation, I'll talk about what automation is, and how to approach implementing it in the context of IT Operations. Ned will discuss keys to success in the long term and include practical real-world examples. Ge...
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, discussed how they built...
When talking IoT we often focus on the devices, the sensors, the hardware itself. The new smart appliances, the new smart or self-driving cars (which are amalgamations of many ‘things'). When we are looking at the world of IoT, we should take a step back, look at the big picture. What value are these devices providing. IoT is not about the devices, its about the data consumed and generated. The devices are tools, mechanisms, conduits. This paper discusses the considerations when dealing with the...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
When building large, cloud-based applications that operate at a high scale, it's important to maintain a high availability and resilience to failures. In order to do that, you must be tolerant of failures, even in light of failures in other areas of your application. "Fly two mistakes high" is an old adage in the radio control airplane hobby. It means, fly high enough so that if you make a mistake, you can continue flying with room to still make mistakes. In his session at 18th Cloud Expo, Le...
Sanjeev Sharma Joins November 11-13, 2018 @DevOpsSummit at @CloudEXPO New York Faculty. Sanjeev Sharma is an internationally known DevOps and Cloud Transformation thought leader, technology executive, and author. Sanjeev's industry experience includes tenures as CTO, Technical Sales leader, and Cloud Architect leader. As an IBM Distinguished Engineer, Sanjeev is recognized at the highest levels of IBM's core of technical leaders.
Machine learning has taken residence at our cities' cores and now we can finally have "smart cities." Cities are a collection of buildings made to provide the structure and safety necessary for people to function, create and survive. Buildings are a pool of ever-changing performance data from large automated systems such as heating and cooling to the people that live and work within them. Through machine learning, buildings can optimize performance, reduce costs, and improve occupant comfort by ...
JETRO showcased Japan Digital Transformation Pavilion at SYS-CON's 21st International Cloud Expo® at the Santa Clara Convention Center in Santa Clara, CA. The Japan External Trade Organization (JETRO) is a non-profit organization that provides business support services to companies expanding to Japan. With the support of JETRO's dedicated staff, clients can incorporate their business; receive visa, immigration, and HR support; find dedicated office space; identify local government subsidies; get...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, we provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Containers and Kubernetes allow for code portability across on-premise VMs, bare metal, or multiple cloud provider environments. Yet, despite this portability promise, developers may include configuration and application definitions that constrain or even eliminate application portability. In this session we'll describe best practices for "configuration as code" in a Kubernetes environment. We will demonstrate how a properly constructed containerized app can be deployed to both Amazon and Azure ...